AstraZeneca Aktie
154,85
EUR
+0,95
EUR
+0,62
%
135,54
GBP
+0,48
GBP
+0,36
%
Werbung
AstraZeneca Aktie Analyse
| 15.05.06 | AstraZeneca neutral | Merrill Lynch | |
| 28.04.06 | AstraZeneca neutral-weight | Prudential Financial | |
| 07.02.06 | AstraZeneca in-line | Goldman Sachs | |
| 06.02.06 | AstraZeneca equal-weight | Morgan Stanley | |
| 03.02.06 | AstraZeneca neutral-weight | Prudential Financial | |
| 03.02.06 | AstraZeneca Peer Perform | Bear Stearns | |
| 03.02.06 | AstraZeneca Neutral | Prudential Securities | |
| 02.02.06 | AstraZeneca neutral-weight | Prudential Financial | |
|
Werbung
|
|||
| 01.02.06 | AstraZeneca neutral | JP Morgan | |
| 28.10.05 | AstraZeneca in-line | Goldman Sachs | |
| 28.10.05 | AstraZeneca neutral-weight | Prudential Financial | |
| 18.10.05 | AstraZeneca neutral | Merrill Lynch | |
| 29.09.05 | AstraZeneca Peer Perform | Bear Stearns | |
| 21.09.05 | AstraZeneca in-line | Goldman Sachs | |
| 19.09.05 | AstraZeneca equal-weight | Morgan Stanley | |
| 01.08.05 | AstraZeneca equal-weight | Morgan Stanley | |
| 29.07.05 | AstraZeneca neutral-weight | Prudential Financial | |
| 28.07.05 | AstraZeneca neutral-weight | Prudential Financial | |
| 26.07.05 | AstraZeneca in-line | Goldman Sachs | |
| 20.07.05 | AstraZeneca neutral | Merrill Lynch | |
| 09.06.05 | AstraZeneca halten | Wertpapier | |
| 30.05.05 | AstraZeneca neutral | Merrill Lynch | |
| 11.05.05 | AstraZeneca In-Line | Goldman Sachs | |
| 05.05.05 | AstraZeneca In-Line | Goldman Sachs | |
| 29.04.05 | AstraZeneca Market Perform | Friedman, Billings Ramsey & Co | |
| 29.04.05 | AstraZeneca Equal weight | Lehman Brothers | |
| 29.04.05 | AstraZeneca In-Line | Goldman Sachs | |
| 19.04.05 | AstraZeneca In-Line | Goldman Sachs | |
| 15.04.05 | AstraZeneca Neutral | HypoVereinsbank | |
| 04.03.05 | AstraZeneca In-Line | Goldman Sachs | |
| 01.02.05 | AstraZeneca Marketperformer | Sparkasse KölnBonn | |
| 28.01.05 | AstraZeneca Equal weight | Lehman Brothers | |
| 28.01.05 | AstraZeneca Halten | LB Baden-Württemberg | |
| 28.01.04 | AstraZeneca In-Line | Goldman Sachs | |
Werbung
Werbung